tiprankstipranks
Trending News
More News >
Fosun International (HK:0656)
:0656

Fosun International (0656) AI Stock Analysis

Compare
1 Followers

Top Page

HK

Fosun International

(OTC:0656)

45Neutral
Fosun International's overall score reflects significant financial challenges, including a high debt load, negative profitability, and weak cash flow. Technical indicators further support a bearish outlook, while valuation metrics highlight underperformance relative to peers. The company must address its financial health to improve stock performance.

Fosun International (0656) vs. S&P 500 (SPY)

Fosun International Business Overview & Revenue Model

Company DescriptionFosun International Limited (0656) is a Chinese multinational conglomerate headquartered in Shanghai. The company operates across various sectors, including healthcare, tourism and leisure, wealth management, and insurance. Fosun is known for its diverse portfolio, which comprises pharmaceuticals, medical services, real estate development, and financial services, making it one of the largest privately-owned enterprises in China. The company leverages its global presence to achieve synergies across its varied business lines, aiming to create value through strategic investments and operations in both domestic and international markets.
How the Company Makes MoneyFosun International generates revenue through a diversified business model that spans multiple sectors. In healthcare, it earns income from the sale of pharmaceuticals and medical devices, as well as providing medical services through its hospital networks. The tourism and leisure sector contributes through the operation of resorts, hotels, and travel services, including its ownership stake in Club Med. In wealth management and insurance, Fosun derives earnings from investment management fees, insurance premiums, and asset management services. The company's real estate operations also contribute significantly, involving the development, sale, and leasing of properties. Key partnerships with other global enterprises enhance its revenue streams by expanding market reach and operational capabilities. Fosun's strategic investments and acquisitions are crucial in maintaining and expanding its revenue base across these sectors.

Fosun International Financial Statement Overview

Summary
Income Statement
Balance Sheet
Cash Flow
Breakdown
Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Income StatementTotal Revenue
198.20B175.39B161.29B136.74B142.98B
Gross Profit
50.80B57.38B55.65B50.59B53.96B
EBIT
2.44B-6.17B-1.75B-457.88M4.56B
EBITDA
30.50B477.14M4.05B5.02B9.32B
Net Income Common Stockholders
1.38B538.72M10.08B8.00B14.80B
Balance SheetCash, Cash Equivalents and Short-Term Investments
152.65B157.80B164.77B173.54B158.04B
Total Assets
808.39B823.15B806.28B767.72B715.68B
Total Debt
233.57B228.36B257.87B250.87B224.97B
Net Debt
153.26B128.29B161.59B145.15B131.33B
Total Liabilities
599.81B623.52B603.16B574.64B534.76B
Stockholders Equity
124.94B121.52B131.00B127.81B122.55B
Cash FlowFree Cash Flow
-3.35B-5.45B-9.64B2.73B2.91B
Operating Cash Flow
9.82B1.76B-3.32B8.89B7.83B
Investing Cash Flow
17.59B35.58B-536.96M612.52M-12.44B
Financing Cash Flow
-39.67B-38.12B-3.66B2.29B-4.75B

Fosun International Technical Analysis

Technical Analysis Sentiment
Negative
Last Price4.03
Price Trends
50DMA
4.31
Negative
100DMA
4.33
Negative
200DMA
4.33
Negative
Market Momentum
MACD
-0.10
Positive
RSI
41.49
Neutral
STOCH
73.15
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0656, the sentiment is Negative. The current price of 4.03 is below the 20-day moving average (MA) of 4.13, below the 50-day MA of 4.31, and below the 200-day MA of 4.33, indicating a bearish trend. The MACD of -0.10 indicates Positive momentum. The RSI at 41.49 is Neutral, neither overbought nor oversold. The STOCH value of 73.15 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0656.

Fosun International Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
£147.39B8.4713.62%6.18%3.98%5.43%
76
Outperform
$180.79B10.3011.23%6.63%-2.77%4.04%
71
Outperform
HK$209.65B12.012.88%5.13%20.91%-29.29%
66
Neutral
€818.17B5.2919.25%8.41%5.62%-0.74%
64
Neutral
HK$123.53B14.0611.92%2.10%17.34%28.21%
63
Neutral
$4.27B11.405.38%214.75%4.10%-8.98%
45
Neutral
HK$32.89B44.05-3.59%0.97%-4.89%-402.47%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:0656
Fosun International
4.03
-0.59
-12.77%
GB:HSBA
HSBC Holdings
834.00
203.02
32.18%
HK:0016
Sun Hung Kai Properties
72.35
2.96
4.27%
HK:0883
CNOOC Limited
16.86
-1.54
-8.39%
HK:0027
Galaxy Entertainment Group
28.25
-7.17
-20.23%
HK:0011
Hang Seng Bank
104.80
7.63
7.86%

Fosun International Corporate Events

Fosun International Announces Acquisition of Henlius Shares
Apr 25, 2025

Fosun International Limited has announced a discloseable transaction concerning the acquisition of unlisted shares of Henlius. This acquisition involves multiple shareholders, with Ms. Tseng Chi-Ling being the largest shareholder of HenLink, the seller. This strategic move is expected to enhance Fosun’s market positioning and potentially impact its stakeholders by expanding its investment portfolio.

Fosun International Announces 2025 AGM with Key Resolutions
Apr 25, 2025

Fosun International Limited has announced its upcoming Annual General Meeting (AGM) scheduled for June 5, 2025, in Shanghai, China. Key agenda items include the presentation of audited financial statements for 2024, the declaration of a final dividend, re-election of directors, and the reappointment of Ernst & Young as auditors. Additionally, resolutions will be considered for the authorization of share purchases and the issuance of new shares, which could impact the company’s market positioning and shareholder value.

Fosun International Expands Stake in Henlius to Strengthen Pharmaceutical Holdings
Apr 21, 2025

Fosun International, through its subsidiary Fosun Pharma Industrial, has increased its stake in Henlius by acquiring additional shares, bringing its total ownership to 63.43%. This acquisition, conducted through a series of transactions, highlights Fosun’s strategic focus on expanding its influence in the pharmaceutical sector. The transactions are classified as discloseable under Hong Kong’s Listing Rules, indicating their significance to the company’s financial and operational strategies.

Fosun International Announces Director Resignation
Apr 11, 2025

Fosun International Limited announced the resignation of Mr. Yu Qingfei from his position as a non-executive director, effective April 11, 2025, due to a reallocation of work. The company expressed gratitude for Mr. Yu’s contributions, and he confirmed no disagreements with the board, ensuring no issues for shareholders or the Hong Kong Stock Exchange.

Fosun International Declares Final Dividend for 2024
Mar 30, 2025

Fosun International Limited has announced a final ordinary cash dividend of HKD 0.02 per share for the financial year ending December 31, 2024. The dividend reflects the company’s commitment to returning value to its shareholders, with the payment scheduled for July 16, 2025, following shareholder approval in June. This announcement underscores Fosun’s stable financial performance and its strategy to maintain investor confidence.

Fosun International Reports 2024 Financial Results Amid Strategic Restructuring
Mar 30, 2025

Fosun International reported a challenging financial year in 2024, with a loss attributable to owners of the parent amounting to RMB 4,348.9 million, compared to a profit in the previous year. Despite the financial setback, the company maintained stability in its core operations and continued its strategy of divesting non-core and heavy assets, amounting to approximately RMB 30 billion at the consolidated level. This strategic focus aims to streamline operations, reduce debt, and create long-term value for shareholders by concentrating on core industries and leveraging globalization and innovation capabilities.

Fosun International Reschedules Board Meeting for Annual Results
Mar 28, 2025

Fosun International Limited has announced a change in the date for its board meeting, originally scheduled for March 31, 2025, to March 30, 2025. This meeting is crucial for approving the annual results for the year ending December 31, 2024, and considering the payment of a final dividend. The rescheduling is due to changes in work arrangements related to the annual results, which may impact the company’s operational timeline and stakeholder expectations.

Fosun International Issues Profit Warning Amid Investment Adjustment
Mar 28, 2025

Fosun International has issued a profit warning for the 2024 financial year, anticipating a significant loss due to a substantial adjustment in the carrying value of its investment in Cainiao Smart Logistics Network Limited. Despite this expected loss, the company’s core operations remain stable, with a clear strategic focus and robust industrial capabilities aimed at ensuring long-term growth.

Fosun’s Fidelidade Reports Strong 2024 Financial Results
Mar 26, 2025

Fosun International’s subsidiary, Fidelidade, has released its financial results for 2024, reporting total assets of EUR 22.05 billion and a net profit of EUR 253.15 million. This financial performance underscores Fidelidade’s robust position in the insurance market, reflecting its capability to generate substantial revenue and profit, which could positively impact Fosun’s overall financial health and appeal to investors.

Yuyuan Reports Significant Financial Decline in 2024
Mar 24, 2025

Shanghai Yuyuan Tourist Mart, a subsidiary of Fosun International, reported a significant decline in its 2024 financial performance. The company’s revenue decreased by 19.30% compared to the previous year, and its net profit attributable to shareholders plummeted by 93.81%. These results highlight challenges in the company’s operations and could impact its market positioning and stakeholder confidence.

Fosun International to Review Annual Results and Dividend
Mar 18, 2025

Fosun International Limited has announced that its board of directors will meet on March 31, 2025, to approve the annual results for the year ending December 31, 2024, and to consider the payment of a final dividend. This meeting is significant as it will determine the company’s financial performance and potential shareholder returns, impacting its market positioning and stakeholder interests.

Fosun International Completes Share Buy-Back of Fosun Tourism Group
Mar 17, 2025

Fosun International announced the successful completion of a share buy-back of Fosun Tourism Group (FTG) through a scheme of arrangement, which has been sanctioned by the Grand Court and registered in the Cayman Islands. This transaction will lead to the withdrawal of FTG shares from the Hong Kong Stock Exchange, effective March 19, 2025. The company expressed gratitude to shareholders and business partners for their support and emphasized its commitment to FTG’s business development and leveraging group synergies.

Fosun International to Divest Equity in Guangzhou Taotall
Mar 14, 2025

Fosun International, through its indirect subsidiary Fosun Joygo, has entered into a Sale and Purchase Agreement with Hangzhou Tianyuan for the disposal of a significant equity interest in Guangzhou Taotall. Fosun Joygo plans to sell 43.9688% of its equity interest, while other shareholders, including Mr. Huang and Mr. Tang, will sell smaller portions. The transaction will be settled through the issuance of A Shares by Hangzhou Tianyuan and/or cash. This move will result in Fosun International no longer holding any equity interest in Guangzhou Taotall, potentially impacting its market positioning and stakeholder interests.

Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.